Longwood Management

Venture Capital Exempt reporting adviser

Legal name: Longwood Management LLC

Boston, MA Website X

AUM

$456.3M
Private fund assets

Private funds

12
Venture Capital 12

Private fund assets

$456.3M
Gross asset value

Employees

—

Last Form D raise

Dec 2024
Most recent fund filing

From SEC Form ADV filing (filed Mar 31, 2026). View on SEC

People(1)

Owners and executive officers named on the firm's SEC Form ADV.

C
Christoph Westphal
Managing Member
Source: SEC Form ADV

Funds(12)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Longwood Special Situations Fund, L.P.Venture Capital$169.1M$157.8M18Dec 2024Cool
Longwood Fund VI, L.P.Venture Capital$106.8M$94.5M23Sep 2022Cold
Longwood Fund V, LPVenture Capital$53.1M$117.8M38Jul 2020Cold
Longwood Fund IV, LPVenture Capital$17.0M——Jul 2016Cold
Longwood Fund III, LPVenture Capital$1.4M——Apr 2015Cold
Longwood Fund II, L.P.Venture Capital$25.1M$66.7M31May 2014Cold
Lf-A Incubator Fund, L.P.Venture Capital$37.2M———
Lf-B Incubator Fund, LLCVenture Capital$16.0M———
Longwood Fund, L.P.Venture Capital$15.8M———
Lf-I Incubator Fund, L.P.Venture Capital$14.6M———
Lf-Cff Incubator Fund, L.P.Venture Capital$184K———
Lfshv, LLCVenture Capital$6K———

Board seats(4)

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

Newleos Therapeutics
BiotechnologyBoston, MADirector: Christoph Westphal
$93.5M raised
Since Feb 2025
SEC Form D
Flex Pharma
BiotechnologyHouston, TXDirector: Christoph Westphal
$24.6M raised
Since Aug 2014
SEC Form D
Pyxis Oncology
Other Health CareCambridge, MADirector: Christoph Westphal
$194.5M raised
Since Jul 2019
SEC Form D
ImmuneID
BiotechnologyBoston, MADirector: Christoph Westphal
$17.1M raised
Since Jan 2021
SEC Form D

Regulatory identifiers

CRD number
281220
SEC file number
802-106563

Sources